Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

2021

Bone Therapeutics to participate in upcoming conferences

  • Read more about Bone Therapeutics to participate in upcoming conferences

Bone Therapeutics Provides First Quarter 2021 Business Update

  • Read more about Bone Therapeutics Provides First Quarter 2021 Business Update

Bone Therapeutics announces Annual General Meeting results

  • Read more about Bone Therapeutics announces Annual General Meeting results

Bone Therapeutics publishes results of ALLOB Phase I/IIa study for the treatment of delayed-union fractures in Stem Cell Research & Therapy

  • Read more about Bone Therapeutics publishes results of ALLOB Phase I/IIa study for the treatment of delayed-union fractures in Stem Cell Research & Therapy

Bone Therapeutics secures up to €16M loan financing from the EIB to accelerate clinical and commercial development of innovative orthopedic treatments

  • Read more about Bone Therapeutics secures up to €16M loan financing from the EIB to accelerate clinical and commercial development of innovative orthopedic treatments

Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 5 August 2021

  • Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 5 August 2021

Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer

  • Read more about Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer

Bone Therapeutics provides update on the progress of clinical studies

  • Read more about Bone Therapeutics provides update on the progress of clinical studies

Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017

  • Read more about Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017

Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021

  • Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to 2021
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions